AAAAAA

   
Results: 1-8 |
Results: 8
SYRINGE USE AND REUSE - EFFECTS OF SYRINGE EXCHANGE PROGRAMS IN 4 CITIES
Authors: HEIMER R KHOSHNOOD K BIGG D GUYDISH J JUNGE B
Citation: R. Heimer et al., SYRINGE USE AND REUSE - EFFECTS OF SYRINGE EXCHANGE PROGRAMS IN 4 CITIES, Journal of acquired immune deficiency syndromes and human retrovirology, 18, 1998, pp. 37-44
COMMUNITY SUPPORT FOR NEEDLE EXCHANGE PROGRAMS AND PHARMACY SALE OF SYRINGES - A HOUSEHOLD SURVEY IN BALTIMORE, MARYLAND
Authors: KEYL PM GRUSKIN L CASANO K MONTAG H JUNGE B VLAHOV D
Citation: Pm. Keyl et al., COMMUNITY SUPPORT FOR NEEDLE EXCHANGE PROGRAMS AND PHARMACY SALE OF SYRINGES - A HOUSEHOLD SURVEY IN BALTIMORE, MARYLAND, Journal of acquired immune deficiency syndromes and human retrovirology, 18, 1998, pp. 82-88
REDUCTIONS IN HIGH-RISK DRUG-USE BEHAVIORS AMONG PARTICIPANTS IN THE BALTIMORE NEEDLE EXCHANGE PROGRAM
Authors: VLAHOV D JUNGE B BROOKMEYER R COHN S RILEY E ARMENIAN H BEILENSON P
Citation: D. Vlahov et al., REDUCTIONS IN HIGH-RISK DRUG-USE BEHAVIORS AMONG PARTICIPANTS IN THE BALTIMORE NEEDLE EXCHANGE PROGRAM, Journal of acquired immune deficiency syndromes and human retrovirology, 16(5), 1997, pp. 400-406
DISCARDED NEEDLES DO NOT INCREASE SOON AFTER THE OPENING OF A NEEDLE EXCHANGE PROGRAM
Authors: DOHERTY MC GARFEIN RS VLAHOV D JUNGE B RATHOUZ PJ GALAI N ANTHONY JC BEILENSON P
Citation: Mc. Doherty et al., DISCARDED NEEDLES DO NOT INCREASE SOON AFTER THE OPENING OF A NEEDLE EXCHANGE PROGRAM, American journal of epidemiology, 145(8), 1997, pp. 730-737
DECREASE OF SOFT VIBRATIONAL-MODES WITH INCREASING DENSITY OF 2-LEVELSTATES IN THE METALLIC-GLASS ZR-RH
Authors: JUNGE B GEY W
Citation: B. Junge et W. Gey, DECREASE OF SOFT VIBRATIONAL-MODES WITH INCREASING DENSITY OF 2-LEVELSTATES IN THE METALLIC-GLASS ZR-RH, Annalen der Physik, 5(7), 1996, pp. 553-558
LEUKOTRIENE SYNTHESIS INHIBITORS OF THE QUINOLINE TYPE - PARAMETERS FOR THE OPTIMIZATION OF EFFICACY
Authors: MATZKE M BECKERMANN B FRUCHTMANN R FUGMANN B GARDINER PJ GOOSSENS J HATZELMANN A JUNGE B KELDENICH J KOHLSDORFER C MOHRS KH MULLERPEDDINGHAUS R RADDATZ S
Citation: M. Matzke et al., LEUKOTRIENE SYNTHESIS INHIBITORS OF THE QUINOLINE TYPE - PARAMETERS FOR THE OPTIMIZATION OF EFFICACY, European journal of medicinal chemistry, 30, 1995, pp. 441-451
BAY-X1005, A NEW SELECTIVE INHIBITOR OF LEUKOTRIENE SYNTHESIS - PHARMACOLOGY AND PHARMACOKINETICS
Authors: MULLERPEDDINGHAUS R FRUCHTMANN R AHR HJ BECKERMANN B BUHNER K FUGMANN B JUNGE B MATZKE M KOHLSDORFER C RADDATZ S THEISENPOPP P MOHRS KH
Citation: R. Mullerpeddinghaus et al., BAY-X1005, A NEW SELECTIVE INHIBITOR OF LEUKOTRIENE SYNTHESIS - PHARMACOLOGY AND PHARMACOKINETICS, Journal of lipid mediators, 6(1-3), 1993, pp. 245-248
IN-VITRO PHARMACOLOGY OF BAY-X1005, A NEW INHIBITOR OF LEUKOTRIENE SYNTHESIS
Authors: FRUCHTMANN R MOHRS KH HATZELMANN A RADDATZ S FUGMANN B JUNGE B HORSTMANN H MULLERPEDDINGHAUS R
Citation: R. Fruchtmann et al., IN-VITRO PHARMACOLOGY OF BAY-X1005, A NEW INHIBITOR OF LEUKOTRIENE SYNTHESIS, Agents and actions, 38(3-4), 1993, pp. 188-195
Risultati: 1-8 |